Universe Pharmaceuticals INC SEC filings UPC
Universe Pharmaceuticals INC has 119 filings in SEC EDGAR's recent list, going back to Apr 24, 2020. Its latest annual report, Form 20-F, was filed on Jan 29, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Oct 6, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 1, 2026 | — |
| 4 | Insider transaction | May 21, 2026 | May 7, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | May 21, 2026 | — |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 7, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 3, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Dec 28, 2021 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UPC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- China
- Headquarters
- Ji'An, Jiangxi, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1809616
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.